News

Divaka Perera, MD, at ACC.26

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  

voice audio recording smartphone

An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.

Thumbnail

Decreased screening rates among different subgroups highlight the ongoing need for outreach strategies that target vulnerable populations, experts contend.

Medtronic’s MiniMed 780G automated insulin delivery system

Nearly 27,000 MiniMed 780G insulin pumps were included in a new Class II recall. By taking a few basic steps, however, patients should be able to avoid any significant risks.

William P. Shutze, MD, FACS, secretary of the Society of Vascular Surgery (SVS), a vascular surgeon with Texas Vascular Associates in Plano, Texas, and a clinical associate professor of medicine at Texas A&M College of Medicine, explained the role of vascular surgeons in peripheral artery disease (PAD) and critical limb ischemia (CLI).

Vascular surgeons perform procedures interventional cardiologists and interventional radiologists do not do—so why not make sure they are part of every heart team conversation?

Northwestern deploys new mobile stroke unit

The MSU operates 365 days a year and covers 138 square miles. Hundreds of patients have been treated through the MSU, with more than 500 receiving critical care in it 2025 alone. 

UnitedHealth Group - 2

Led by a Quebec-based faith organization, a coalition of investors is asking a court to force UnitedHealth to provide details on the social impacts of its history of mergers and acquisitions. The lawsuit comes after the plaintiffs, all company shareholders, failed to get the proposal passed through internal channels. The Securities and Exchange Commission has also opted not to intervene. 

Cardiothoracic surgeons at Emory University Hospital have implanted the BrioVAD System, a new type of ventricular assist device (VAD) from BrioHealth Solutions, for the very first time in the United States.

Cardiothoracic surgeons at Emory University Hospital implanted the BrioVAD System, a new type of ventricular assist device from BrioHealth Solutions, for the very first time in the United States. The advanced technology, designed to minimize adverse events and improve quality of life, has been under development since 2008. 

Cleerly cardiology

If not for AI analysis of a CT scan showing his heart and coronary arteries, patient James Doe—not his real name—may have died of a “widowmaker” heart attack before experiencing a single symptom. 

Sapien 3 Ultra Resilia TAVR valves

The Sapien 3 Ultra Resilia TAVR valve from Edwards Lifesciences is associated with a significantly higher survival rate after one year than the company's previous balloon-expandable valves. Researchers identified other key benefits as well, sharing their findings in JACC: Cardiovascular Interventions.

Thumbnail

The problem is particularly pronounced among members of the specialty who already have a high workload or are skeptical of artificial intelligence. 

Around the web

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.